Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009471
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-06-25
Brief Title:
A Multicenter Clinical Study of rTMS for Parkinsons Disease
Sponsor:
Affiliated Hospital of Nantong University
Organization:
Affiliated Hospital of Nantong University
Study Overview
Official Title:
A Multicenter Clinical Study of rTMS for Parkinsons Disease
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Through rTMS motor dysfunction and non-motor dysfunction of PD patients can be improved working and living ability and quality of life of patients can be improved and social burden and family burden can be reduced
Detailed Description:
According to the inclusion criteria a total of 200 patients with Parkinsons disease were planned to be enrolled in each center and randomly divided into control group conventional treatment and observation group conventional treatment rTMS for a treatment cycle of 4 weeks They were followed up for 3 months before treatment 2 weeks and 4 weeks respectively after treatment to evaluate the efficacy and function The unified Parkinsons Disease Rating Scale UPDRS was used Cognitive function assessment Monteller Cognitive Assessment Scale MoCA Barthel Index for daily living activities Depression assessment Hamilton Depression Scale HAMD Hamilton Anxiety Scale HAMA Sleep assessment PD Sleep Scale PDSS Pain assessment King Parkinsons Pain Assessment KPPS and adverse events were recorded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None